| |
Size of Population Served
| | |
|---|
| |
Small (< 50,000)
|
Medium (50,000-499,999)
|
Large (500,000+)
|
All LHDs
|
|---|
|
Eligible Group
|
n
|
(%)
|
n
|
(%)
|
n
|
(%)
|
n
|
(%)
|
|---|
|
Household members of persons with H1N1 influenza
|
3
|
(100)
|
10
|
(77)
|
4
|
(44)
|
17
|
(68)
|
|
Persons at high-risk for medical complications of influenza (e.g. pregnant women)
|
3
|
(100)
|
4
|
(31)
|
5
|
(56)
|
12
|
(48)
|
|
Healthcare workers
|
2
|
(67)
|
4
|
(31)
|
3
|
(33)
|
9
|
(36)
|
|
Other first responders
|
2
|
(67)
|
1
|
(8)
|
1
|
(11)
|
4
|
(16)
|
|
Household members of healthcare workers
|
1
|
(33)
|
0
|
(0)
|
1
|
(11)
|
2
|
(8)
|
|
Other
|
0
|
(0)
|
3
|
(23)
|
3
|
(33)
|
6
|
(24)
|
|
Don't know/Unable to answer
|
0
|
(0)
|
2
|
(15)
|
2
|
(22)
|
4
|
(16)
|
|
Total
|
3
| |
13
| |
9
| |
25
| |
- Among the twenty-five local health departments (LHDs) reporting that publicly purchased antivirals could be used for pre- or post-prophylaxis, Table 4 summarizes the groups eligible for prophylaxis with publicly purchased antivirals, stratified by size of population served by LHD
- **Indicates statistically significant difference with respect to population size served by LHD (Fisher's exact test, p < .05)
